pLKO.1 puro-humanU6-shRNA FASN Citations (2)
Originally described in: Elizabeth Stoll plasmidsUnpublished
Articles Citing pLKO.1 puro-humanU6-shRNA FASN
| Articles |
|---|
| Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest. Cenigaonandia-Campillo A, Garcia-Bautista A, Rio-Vilarino A, Cebrian A, Del Puerto L, Pellicer JA, Gabaldon JA, Perez-Sanchez H, Carmena-Bargueno M, Merono C, Traba J, Fernandez-Acenero MJ, Banos-Herraiz N, Mozas-Vivar L, Nunez-Delicado E, Garcia-Foncillas J, Aguilera O. Mol Oncol. 2024 Feb 29. doi: 10.1002/1878-0261.13616. PubMed |
| Valproic acid targets IDH1 mutants through alteration of lipid metabolism. Elahi LS, Condro MC, Kawaguchi R, Qin Y, Alvarado AG, Gruender B, Qi H, Li T, Lai A, Castro MG, Lowenstein PR, Garrett MC, Kornblum HI. NPJ Metab Health Dis. 2024;2(1):20. doi: 10.1038/s44324-024-00021-6. Epub 2024 Aug 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.